Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Neurological Sciences
Published in: Neurological Sciences 9/2020

01-09-2020 | Lung Cancer | Letter to the Editor

Paraneoplastic basal ganglia encephalitis associated with anti-CV2/CRMP-5 and anti-Yo antibodies in a patient with non-small-cell lung cancer

Authors: Aigli Vakrakou, Vasilios C. Constantinides, George Velonakis, John S. Tzartos, Leonidas Stefanis, Elisabeth Kapaki, George P. Paraskevas

Published in: Neurological Sciences | Issue 9/2020

Login to get access

Excerpt

Dear Editor. …
Appendix
Available only for authorised users
Literature
1.
Poplawska-Domaszewicz K, Florczak-Wyspianska J, Kozubski W, Michalak S (2018) Paraneoplastic movement disorders. Rev Neurosci 29(7):745–755PubMedCrossRef
2.
Balint B, Vincent A, Meinck HM, Irani SR, Bhatia KP (2018) Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology. Brain 141(1):13–36PubMedCrossRef
3.
Mohammad SS, Ramanathan S, Brilot F, Dale RC (2013) Autoantibody-associated movement disorders. Neuropediatrics. 44(6):336–345PubMedCrossRef
4.
Tani T, Piao Y, Mori S, Ishihara N, Tanaka K, Wakabayashi K, Takahashi H (2000) Chorea resulting from paraneoplastic striatal encephalitis. J Neurol Neurosurg Psychiatry 69(4):512–515PubMedPubMedCentralCrossRef
5.
Vernino S, Tuite P, Adler CH, Meschia JF, Boeve BF, Boasberg P, Parisi JE, Lennon VA (2002) Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol 51(5):625–630PubMedCrossRef
6.
Greenlee JE, Clawson SA, Hill KE, Wood BL, Tsunoda I, Carlson NG (2010) Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures. J Neuropathol Exp Neurol 69(10):997–1007PubMedPubMedCentralCrossRef
7.
Greenlee JE, Clawson SA, Hill KE, Wood B, Clardy SL, Tsunoda I, Carlson NG (2015) Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers. PLoS One 10(4):e0123446PubMedPubMedCentralCrossRef
8.
Vigliani MC, Honnorat J, Antoine JC, Vitaliani R, Giometto B, Psimaras D et al (2011) Chorea and related movement disorders of paraneoplastic origin: the PNS EuroNetwork experience. J Neurol 258(11):2058–2068PubMedCrossRef
9.
Honnorat J, Cartalat-Carel S, Ricard D, Camdessanche JP, Carpentier AF, Rogemond V et al (2009) Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry 80(4):412–416PubMedCrossRef
10.
Dericioglu N, Gocmen R, Tan E (2018) Paraneoplastic striatal encephalitis and myelitis associated with anti-CV2/CRMP-5 antibodies in a patient with small cell lung cancer. Clin Neurol Neurosurg 170:117–119PubMedCrossRef
11.
Aliprandi A, Terruzzi A, Rigamonti A, Bazzigaluppi E, Tremolizzo L, Ferrarese C, Salmaggi A (2015) Paraneoplastic cerebellar degeneration with anti-CV2/CRMP5 antibodies and prostate adenocarcinoma. Neurol Sci 36(8):1501–1503PubMedCrossRef
12.
Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA (2001) CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 49(2):146–154PubMedCrossRef
13.
Tada S, Furuta M, Fukada K, Hirozawa D, Matsui M, Aoike F, Okuno T, Sawada JI, Mochizuki H, Hazama T (2016) Severe parkinsonism associated with anti-CRMP5 antibody-positive paraneoplastic neurological syndrome and abnormal signal intensity in the bilateral basal ganglia. J Neurol Neurosurg Psychiatry 87(8):907–910PubMedCrossRef
Metadata
Title
Paraneoplastic basal ganglia encephalitis associated with anti-CV2/CRMP-5 and anti-Yo antibodies in a patient with non-small-cell lung cancer
Authors
Aigli Vakrakou
Vasilios C. Constantinides
George Velonakis
John S. Tzartos
Leonidas Stefanis
Elisabeth Kapaki
George P. Paraskevas
Publication date
01-09-2020
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 9/2020
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-020-04399-1

Other articles of this Issue 9/2020

Neurological Sciences 9/2020 Go to the issue

Letter to the Editor

Foreign accent syndrome following herpes simplex encephalitis: a case report

Original Article

Plasma exchange in acute attacks of demyelinating diseases of the central nervous system: clinical outcomes and predictors of response

Original Article

The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and population

Letter to the Editor

Recurrent laryngospasm as the only presenting feature of multiple system atrophy

COVID-19

The emotional impact of COVID-19 outbreak in amyotrophic lateral sclerosis patients: evaluation of depression, anxiety and interoceptive awareness

COVID-19

Effect of lockdown on the management of ischemic stroke: an Italian experience from a COVID hospital